Sea surface salinity (SSS) plays an important role in global water cycle. In recent years, satellite based remote sensing has proven to be a promising approach for global SSS observation. A new payload concept, named MICAP (microwave imager combined active and passive), has been introduced in this paper. MICAP is a suit of active/passive instrument package, which includes L/C/K band one-dimensional MIR (microwave interferometric radiometer) and L-band DBF (digital beamforming) scatterometer, sharing a parabolic cylinder reflector. MICAP has been selected to be a candidate payload for future Chinese ocean salinity mission. In this paper, the MICAP instrument concept, specification and preliminary system design will be introduced.
The new energy demonstration city policy is a significant pilot measure to promote the transition of China’s energy system, aiming at developing new, green, and low-carbon sources of energy. In this paper, the Non-radial Directional Distance Function (NDDF) was adopted to calculate the Energy-Carbon Performance Index (ECPI) of Chinese 182 cities, for measuring the Energy-Carbon Performance (ECP) level of each city. On this basis, it is possible to empirically analyse the impact that the policy orientation of constructing new energy demonstration cities has had on urban energy carbon performance by using a combination of Propensity Score Matching and Difference-in-Difference. Moreover, a mediating effect model is utilised to test the mediating effect of technological innovation. The results show that the new energy demonstration city policy can significantly improve the ECP. Technological innovation has a partial mediating effect between the policy orientation of new energy demonstration city construction and ECP, which accounts for 12.92% of the total effect. Optimising the industrial structure, improving the level of economic development, increasing carbon sink resources, and attracting foreign direct investment all have significant impacts on the improvement of China’s ECP, while the urbanisation process has an inhibitory effect on the improvement of ECP. Heterogeneity analysis shows that policy orientation has a better driving effect on eastern cities and western cities in promoting the improvement of ECP. The policy implications of this paper are that 1) The government should expand the scope of new energy city pilots in an orderly manner; 2) The lasting and long-term influence of policy orientation on ECP should make use of technological innovation intermediary channels; 3) Support policies are supposed to formulate according to local conditions.
15 June 2021 in Journal of Cardiovascular Pharmacology
Introduction: Our study aimed to investigate the effect of atorvastatin on plaque calcification by matching the results obtained by 18F-sodium fluoride (18F-NaF) positron emission tomography (PET)/computed tomography (CT) with data from histologic sections. Methods and Results: The rabbits were divided into 2 groups as follows: an atherosclerosis group (n = 10) and an atorvastatin group (n = 10). All rabbits underwent an abdominal aortic operation and were fed a high-fat diet to induce atherosclerosis. Plasma samples were used to analyze serum inflammation markers and blood lipid levels. 18F-NaF PET/CT scans were performed twice. The plaque area, macrophage number and calcification were measured, and the data from the pathological sections were matched with the 18F-NaF PET/CT scan results. The mean standardized uptake value (0.725 ± 0.126 vs. 0.603 ± 0.071, P < 0.001) and maximum standardized uptake value (1.024 ± 0.116 vs. 0.854 ± 0.091, P < 0.001) significantly increased in the atherosclerosis group, but only slightly increased in the atorvastatin group (0.616 ± 0.103 vs. 0.613 ± 0.094, P = 0.384; 0.853 ± 0.099 vs.0.837 ± 0.089, P < 0.001, respectively). The total calcium density was significantly increased in rabbits treated with atorvastatin compared with rabbits not treated with atorvastatin (1.64 ± 0.90 vs. 0.49 ± 0.35, P < 0.001), but the microcalcification level was significantly lower. There were more microcalcification deposits in the areas with increased radioactive uptake of 18F-NaF. Conclusions: Our study suggests that the anti-inflammatory activity of atorvastatin may promote macrocalcification but not microcalcification within atherosclerotic plaques. 18F-NaF PET/CT can detect plaque microcalcifications.
21 April 2020 in Journal of Interventional Cardiology
Background. Many studies have compared the outcomes of coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI) for complex coronary artery disease (CAD). However, no trials have focused on young patients (<45 years) with complex CAD. We conducted a retrospective evaluation to compare the outcomes of a second-generation drug-eluting stent (DES) and CABG in young patients with LM or three-vessel disease. Methods. In young patients with complex CAD who underwent PCI or CABG, a Kaplan-Meier analysis and Cox regression before and after propensity score matching were used to compare major adverse cardiac and cerebrovascular events (MACCE), including myocardial infarction (MI), stroke, death, and repeat revascularization. Results. During follow-up, MACCE occurred in 20.5% of patients in the PCI group and 8.6% of patients in the CABG group (hazard ratio (HR): 3.263, 95% confidence interval (CI): 1.379 to 7.722, ). Repeat revascularization occurred more frequently in the PCI group (18.9% vs. 3.7%, respectively, HR: 6.968, 95% CI: 2.036 to 23.842, ). There were no significant differences in the other endpoints. After propensity score matching, no conclusions were modified. Conclusions. In young patients with LM or three-vessel disease, PCI showed a higher incidence of MACCE, which was mainly driven by repeat revascularization. However, this did not translate into hard endpoint differences. Therefore, PCI is an alternative treatment to CABG in young patients with complex CAD.
21 April 2021 in Journal of Interventional Cardiology
Background. Whether good glycemic control can result in clinical benefits for diabetic chronic total occlusion (CTO) patients is still a matter of debate. Methods. We studied 1029 diabetic CTO patients. Based on one-year glycosylated hemoglobin A (HbA1c) levels, we assigned the patients into 2 groups: HbA1c<7% group (n = 448) and HbA1c ≥ 7% group (n = 581). We further subdivided the patients into the successful CTO revascularization (CTO-SR) and nonsuccessful CTO revascularization (CTO-NSR) groups. Kaplan–Meier analysis and Cox regression before and after propensity score matching were used to compare major adverse cardiovascular events (MACE) and other endpoints. Results. There were no significant differences between the groups in terms of most endpoints in the overall patients. After propensity score-matched analysis, patients with HbA1c < 7.0 tended to be superior in terms of MACE, which was mainly attributed to repeat revascularization but the other endpoints. Furthermore, the benefit of the HbA1c < 7 group was more prominent among patients with CTO-NSR in terms of MACE, repeat revascularization, and target vessel revascularization (TVR); and the improvement of the HbAc1 < 7 group was more prominent among patients without chronic heart failure (CHF) ( ). Conclusions. HbA1c < 7.0 was associated with a reduced incidence of MACE, which was mainly attributed to a reduction in repeat revascularization. Good glycemic control can improve diabetic CTO patients’ clinical prognosis, especially in CTO-NSR patients.